Abstract: A stent or other prosthesis may be formed by coating a single continuous wire scaffold with a polymer coating. The polymer coating may consist of layers of electrospun polytetrafluoroethylene (PTFE). Electrospun PTFE of certain porosities may permit endothelial cell growth within the prosthesis.

Abstract: Stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.

Abstract: A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.

Abstract: A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.

Abstract: A vascular prosthesis deployment device and related methods are disclosed. In some embodiments the deployment device may include a delivery catheter assembly. The delivery catheter assembly may include a pliant member, wherein the pliant member is configured receive a vascular prosthesis. The pliant member may also be configured to aid in incrementally deploying a vascular prosthesis.

Abstract: Transluminal stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.

Abstract: A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.

Abstract: A stent or other prosthesis may be formed by coating a single continuous wire scaffold with a polymer coating. The polymer coating may consist of layers of electrospun polytetrafluoroethylene (PTFE). Electrospun PTFE of certain porosities may permit endothelial cell growth within the prosthesis.

Abstract: A stent or other prosthesis may be formed by coating a single continuous wire scaffold with a polymer coating. The polymer coating may consist of layers of electrospun polytetrafluoroethylene (PTFE). Electrospun PTFE of certain porosities may permit endothelial cell growth within the prosthesis.

Abstract: Delivery systems and methods for deploying an implantable device are disclosed, which can include a delivery device having an outer tubular member and an inner assembly. The inner assembly is disposed within and is slidably movable relative to the outer tubular member. The inner assembly can include a pusher at a distal portion. The pusher abuts and restricts proximal movement, relative to the inner assembly, of a crimped implantable device within the outer tubular member. The pusher can include a slot to accommodate a suture binding mechanism of the implantable device. The delivery device can include a tip disposed at a distal end. The tip includes a tip transition zone. The inner sheath and outer tubular member can each have sections of distinct rigidity along their lengths with transition zones between the sections. A transition zone of the outer tubular member and a transition zone of the inner sheath can be longitudinally offset.

Abstract: Implantable device embodiments, such as stents, and particularly esophageal stents, formed of a scaffolding structure are disclosed. The scaffolding structure is formed of one or more strand elements arranged in a braided pattern. A covering may coat the scaffolding structure. A valve can be secured to the scaffolding structure and/or the covering. Anti-migration features may be formed by bends in the one or more strand elements. The bends forming the anti-migration features protrude outwardly away from an outer surface of the implantable device.

Abstract: A medical appliance or prosthesis may comprise one or more layers of electrospun nanofibers, including electrospun polymers. The electrospun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Electrospun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis.

Abstract: Delivery systems and methods for deploying an implantable device are disclosed, which can include a delivery device having an outer tubular member and an inner assembly. The inner assembly is disposed within and is slidably movable relative to the outer tubular member. The inner assembly can include a pusher at a distal portion. The pusher abuts and restricts proximal movement, relative to the inner assembly, of a crimped implantable device within the outer tubular member. The pusher can include a slot to accommodate a suture binding mechanism of the implantable device. The delivery device can include a tip disposed at a distal end. The tip includes a tip transition zone. The inner sheath and outer tubular member can each have sections of distinct rigidity along their lengths with transition zones between the sections. A transition zone of the outer tubular member and a transition zone of the inner sheath can be longitudinally offset.

Abstract: A stent comprised of a scaffolding structure having components configured to allow at least a portion of the stent to decrease in diameter in response to an axial force applied to the stent. Further, the components and elements of the stent may be configured to balance transverse forces applied to the stent, thus reducing the incidence of infolding.

Abstract: A vascular prosthesis deployment device and related methods are disclosed. In some embodiments the deployment device may provide audible, tactile, or visual feedback to a practitioner as to the degree of deployment of a prosthesis. The deployment device may also provide mechanical advantage when deploying a prosthesis. The deployment device may be configured to incrementally deploy a prosthesis.

Abstract: Stents may be deployed within a patient, such as in a lung of a patient, by inserting a stent deployment device through a channel (such as a channel of a bronchoscope) and then deploying the stent via manipulation of the stent deployment device. The stents may include one or more features that facilitate or enable positioning of the stent at a location that is distal of the right bronchus or the left bronchus. Related devices, systems, and methods are also disclosed.

Abstract: Prosthesis deployment devices are disclosed herein. In some embodiments, the prosthesis deployment device comprises an elongate delivery catheter assembly configured for electrosurgery and also configured to retain and deploy a prosthesis. Kits comprising the prosthesis deployment devices with a prosthesis loaded into a prosthesis pod of the device are disclosed herein as well as methods of using the prosthesis deployment devices.

Abstract: Transluminal stents are disclosed herein. In some embodiments stents within the scope of this disclosure may comprise a first flared end and second flared end. In some embodiments, a profile of each of the first flared end and the second flared end may circumscribe a portion of separate elliptical arcs. In some embodiments, the stents are formed from braided or woven wires having a constant pitch along a middle region and continuously varying pitches along the first flared end and the second flared end. Methods of manufacturing stents are disclosed herein. Methods of using stents are also disclosed herein.

Abstract: A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.

Abstract: A medical appliance or prosthesis may comprise one or more layers of rotational spun nanofibers, including rotational spun polymers. The rotational spun material may comprise layers including layers of polytetrafluoroethylene (PTFE). Rotational spun nanofiber mats of certain porosities may permit tissue ingrowth into or attachment to the prosthesis. Additionally, one or more cuffs may be configured to allow tissue ingrowth to anchor the prosthesis.